BeOne Medicines
Colin Chua is a seasoned professional in clinical operations with extensive experience in managing clinical studies and teams. Currently serving as a Senior Regional Clinical Study Manager and Clinical Operations Manager at BeiGene since October 2018, Colin has previously held roles as a Clinical Team Leader at Covance from 2015 to 2018 and as a Senior Clinical Research Associate at Covance Pty Ltd from 2011 to 2015. Colin began the career as a Clinical Research Associate at Parexel in 2007 and subsequently progressed through Quintiles Malaysia in various positions, culminating as a Senior Clinical Research Associate. Colin earned a Bachelor of Science degree in Biotechnology from Monash University between 2002 and 2004.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.